Deucravacitinib Impurity 64
- CAS2245111-18-4
- CatalogueRS-D081011
- FormulaC19H19N7O4
- MW409.4
On this page
Product identification
| Product name | Deucravacitinib Impurity 64 |
|---|---|
| Catalogue No. | RS-D081011 |
| CAS No. | 2245111-18-4 |
| Molecular formula | C19H19N7O4 |
| Molecular weight | 409.4 |
| Availability | Back order— restocking can be arranged, about 1–2 weeks |
| Standard type | Impurity Reference Standards |
| Drug substance | Deucravacitinib |
| Also known as | 6-(Cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)pyridazine-3-carboxylic Acid; Deucravacitinib Acid impurity; Deucravacitinib Impurity 44 |
| Storage | Refer to the certificate of analysis (COA) supplied with each lot |
| Intended use | For laboratory and research use only. Not for human or veterinary use. |
What is stated on the certificate
Content and purity are assigned per lot and stated on the certificate of analysis issued for the batch you receive — they are not a catalogue-level figure. The certificate records the tests performed, the specification applied and the result obtained for that lot.
| Field | Basis |
|---|---|
| Identity | Spectroscopic and chromatographic methods appropriate to the material |
| Purity | Chromatographic purity, area normalisation unless stated otherwise |
| Assay / content | Mass balance, corrected for the stated volatiles and residue |
| Catalogue and batch numbers | RS-D081011 / batch number on the certificate |
| Retest date | Printed on the certificate for the lot supplied |
Frequently asked
What documentation is supplied with this lot?
Is the assigned value given on an “as is” basis?
How should this material be stored?
Do you supply pack sizes other than those listed?
Finding this standard
Buyers reach this compound by CAS number, by catalogue number, through the drug substance it belongs to, or through the type of standard it is. Those routes all start here:
- Other impurities of Deucravacitinib
- Impurity Reference Standards of this kind
- Documents for this item (COA, SDS)
- Certificate of analysis for RS-D081011
- Request a quotation for RS-D081011
Searching another way? Send the structure, a SMILES string or the pharmacopoeial name — a CAS number is not required for a non-compendial impurity. Write to sales@rssechem.com.
Other standards of Deucravacitinib
All 51 further standards are listed here — every link is in the page, not loaded later.
-
Deucravacitinib
IN STOCKRS-I097380 -
1H-1,2,4-Triazole, 3-(5-chloro-2-methoxy-3-nitrophenyl)-1-methyl-
BACK ORDERRS-U015913 -
2-(1-Methyl-1H-1,2,4-triazol-3-yl)-6-nitrophenol
CUSTOM SYNTHESISRS-I015407 -
2-Methoxy-3-nitrobenzamide
IN STOCKRS-U053867 -
2-Methoxy-3-nitrobenzonitrile
IN STOCKRS-U053369 -
4,6-Dichloro-N-(methyl-d3)pyridazine-3-carboxamide
IN STOCKRS-D081033 -
4,6-Dihydroxypyridazine-3-carboxylic acid
IN STOCKRS-I010197 -
4-Bromo-2-methoxybenzonitrile
CUSTOM SYNTHESISRS-I012340 -
BMS-986202
BACK ORDERRS-U091525 -
Deucravacitinib D6 (Possibility-1)
IN STOCKRS-D081015 -
Ethyl 4,6-dichloropyridazine-3-carboxylate
IN STOCKRS-U095312 -
Ethyl 4-hydroxy-6-oxo-1,6-dihydropyridazine-3-carboxylate
IN STOCKRS-U095104 -
Lithium 4,6-dichloropyridazine-3-carboxylate
IN STOCKRS-I017075 -
Methyl 2-methoxy-3-nitrobenzimidothioate
IN STOCKRS-U082661 -
Methyl 4,6-dichloropyridazine-3-carboxylate
IN STOCKRS-U082703 -
Methyl 4-hydroxy-6-oxo-1,6-dihydropyridazine-3-carboxylate
IN STOCKRS-U082702 -
Methyl 6-chloro-4-methylpyridazine-3-carboxylate
IN STOCKRS-U082063 -
N-Methyl-N-formylhydrazine
IN STOCKRS-P025450 -
Deucravacitinib N-Oxide Impurity 1
CUSTOM SYNTHESISRS-Z413DI9 -
Deucravacitinib Impurity 4
IN STOCKRS-D081005 -
Deucravacitinib Impurity 12
IN STOCKRS-D081008 -
Deucravacitinib Impurity 14
IN STOCKRS-D081018 -
Deucravacitinib Impurity 18-d3 (BMT-153261)
BACK ORDERRS-D081001 -
Deucravacitinib Impurity 19-d3
IN STOCKRS-D081014 -
Deucravacitinib Impurity 29
BACK ORDERRS-D081029 -
Deucravacitinib Impurity 34
BACK ORDERRS-Z401HK9 -
Deucravacitinib Impurity 45
CUSTOM SYNTHESISRS-D081034 -
Deucravacitinib Impurity 49-d3
BACK ORDERRS-D081020 -
Deucravacitinib Impurity 61
BACK ORDERRS-D081004 -
Deucravacitinib Impurity 62
IN STOCKRS-D081007 -
Deucravacitinib Impurity 63
CUSTOM SYNTHESISRS-D081009 -
Deucravacitinib Impurity 65
BACK ORDERRS-D081016 -
Deucravacitinib Impurity 66
IN STOCKRS-D081017 -
Deucravacitinib Impurity 67
IN STOCKRS-D081021 -
Deucravacitinib Impurity 68
IN STOCKRS-D081022 -
Deucravacitinib Impurity 69
BACK ORDERRS-D081024 -
Deucravacitinib Impurity 70
CUSTOM SYNTHESISRS-D081026 -
Deucravacitinib Impurity 71
IN STOCKRS-D081027 -
Deucravacitinib Impurity 76
IN STOCKRS-D081040 -
Deucravacitinib Impurity 80
IN STOCKRS-D081044 -
Deucravacitinib Impurity 81
IN STOCKRS-D081045 -
Deucravacitinib Impurity 94
IN STOCKRS-D081002 -
Deucravacitinib Impurity 95
CUSTOM SYNTHESISRS-D081006 -
Deucravacitinib Impurity 96
CUSTOM SYNTHESISRS-D081010 -
Deucravacitinib Impurity 97
IN STOCKRS-D081012 -
Deucravacitinib Impurity 98
CUSTOM SYNTHESISRS-D081013 -
Deucravacitinib Impurity 99
BACK ORDERRS-D081019 -
Deucravacitinib Impurity 101
BACK ORDERRS-D081028 -
Deucravacitinib Impurity 102
BACK ORDERRS-D081031 -
Deucravacitinib Impurity 104
BACK ORDERRS-D081039 -
Deucravacitinib Impurity 124
CUSTOM SYNTHESISRS-U006204
Pharmacopoeial names (EP, USP, BP, JP) are used for identification purposes only and do not imply endorsement by those bodies. This product is supplied for laboratory and research use only — not for human or veterinary use.

















































